HRTS Among Its Peers
End-of-day Nov 20, 2026 · 1 ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.0% | −6.2% | −2.6% | −4.3% | +4.3% | +8.0% | — | — | — | +42.1% |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$125 of every $1,000 in HRTS is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 12.54% | $1,254.18 | 5,107 | $6.9M |
| 2 | TMOThermo Fisher Scientific | Healthcare | 5.48% | $548.45 | 4,381 | $3.0M |
| 3 | RHHBYRoche AG | Healthcare | 4.42% | $442.08 | 41K | $2.4M |
| 4 | MRKMerck | Healthcare | 3.97% | $397.34 | 16K | $2.2M |
| 5 | BBIOBridgebio Pharma | Healthcare | 3.87% | $387.18 | 27K | $2.1M |
| 6 | KODKodiak Sciences | Healthcare | 3.85% | $384.57 | 22K | $2.1M |
| 7 | GILDGilead Sciences | Healthcare | 3.52% | $352.45 | 12K | $1.9M |
| 8 | DHRDanaher | Healthcare | 3.19% | $318.65 | 7,704 | $1.8M |
| 9 | RVMDRevolution Medicines | Healthcare | 3.09% | $309.02 | 11K | $1.7M |
| 10 | NOVO-B.CONovo Nordisk A/S | Healthcare | 2.97% | $296.80 | 42K | $1.6M |
| 11 | ABTAbbott Laboratories | Healthcare | 2.93% | $292.58 | 15K | $1.6M |
| 12 | AZN.LAstrazeneca | Healthcare | 2.90% | $290.06 | 9,157 | $1.6M |
| 13 | JNJJohnson & Johnson | Healthcare | 2.84% | $284.10 | 5,851 | $1.6M |
| 14 | NOVN.SWNovartis AG | Healthcare | 2.79% | $278.89 | 10K | $1.5M |
| 15 | VRTXVertex Pharmaceuticals | Healthcare | 2.64% | $263.66 | 2,786 | $1.5M |
HRTS has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 12.54% |
| 2 | TMO | Thermo Fisher Scientific | 5.48% |
| 3 | RHHBY | Roche AG | 4.42% |
| 4 | MRK | Merck & | 3.97% |
| 5 | BBIO | Bridgebio Pharma | 3.87% |
| 6 | KOD | Kodiak Sciences | 3.85% |
| 7 | GILD | Gilead Sciences | 3.52% |
| 8 | DHR | Danaher | 3.19% |
| 9 | RVMD | Revolution Medicines | 3.09% |
| 10 | NOVO-B.CO | Novo Nordisk A/S | 2.97% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| HRTS | 0.27 | 0.42 | 17.4% | −11.0% | 0.49 | $99 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | $0.47 |
| Dec 11, 2024 | Dec 12, 2024 | $0.47 |